Leserbrief

Sehr geehrte Herausgeber,

wir haben mit großem Interesse den CME-Fortbildungsartikel „Muskelrelaxierung bei pädiatrischen Patient*innen“ gelesen. Hierbei handelt es sich um ein essenzielles Thema im Bereich der Kinderanästhesie. Wir möchten hierzu einige Kommentare abgeben und Ergänzungen vornehmen, die uns als sehr wichtig erscheinen.10.1055/a-2348-2556

Publication History

Article published online:
17 February 2025

• Literatur

• 1 Klucka J, Kosinova M, Krikava I. et al. Residual neuromuscular block in paediatric anaesthesia. Br J Anaesth 2019; 122: e1-e2
• 2 Ledowski T, OʼDea B, Meyerkort L. et al. Postoperative Residual Neuromuscular Paralysis at an Australian Tertiary Childrenʼs Hospital. Anesthesiol Res Pract 2015; 2015: 410248
• 3 Faulk DJ, Austin TM, Thomas JJ. et al. A Survey of the Society for Pediatric Anesthesia on the Use, Monitoring, and Antagonism of Neuromuscular Blockade. Anesth Analg 2021; 132: 1518-1526
• 4 Keil O, Rigterink V. [Neuromuscular Blockade in Paediatric Patients]. Anasthesiol Intensivmed Notfallmed Schmerzther 2024; 59: 518-527
• 5 Keil O, Brunsmann K, Boethig D. et al. Incidence and characteristics of errors detected by a short team briefing in pediatric anesthesia. Paediatr Anaesth 2022; 32: 1144-1150
• 6 Scheffenbichler FT, Rudolph MI, Friedrich S. et al. Effects of high neuromuscular blocking agent dose on post-operative respiratory complications in infants and children. Acta Anaesthesiol Scand 2020; 64: 156-167
• 7 Soffer OD, Kim A, Underwood E. et al. Neurophysiological Assessment of Prolonged Recovery From Neuromuscular Blockade in the Neonatal Intensive Care Unit. Front Pediatr 2020; 8: 580
• 8 Guo J, Zhou X, Yuan X. et al. Age and the neuromuscular blockading effects of cisatracurium. Int J Clin Exp Med 2015; 8: 16664-16669
• 9 von Ungern-Sternberg BS, Hammer J, Schibler A. et al. Decrease of functional residual capacity and ventilation homogeneity after neuromuscular blockade in anesthetized young infants and preschool children. Anesthesiology 2006; 105: 670-675
• 10 Trachsel D, Svendsen J, Erb TO. et al. Effects of anaesthesia on paediatric lung function. Br J Anaesth 2016; 117: 151-163
• 11 Isono S, Tanaka A, Ishikawa T. et al. Developmental changes in collapsibility of the passive pharynx during infancy. Am J Respir Crit Care Med 2000; 162: 832-836
• 12 Jalkanen L, Meretoja OA, Taivainen T. et al. Synergism between atracurium and mivacurium compared with that between vecuronium and mivacurium. Anesth Analg 1994; 79: 998-1002
• 13 Gilbertson LE, Fiedorek MC, Fiedorek CS. et al. Prolonged neuromuscular block after rocuronium administration in laparoscopic pyloromyotomy patients: A retrospective bayesian regression analysis. Paediatr Anaesth 2021; 31: 290-297
• 14 Vested M, Tarpgaard M, Eriksen K. et al. Incidence of residual neuromuscular blockade in children below 3 years after a single bolus of cisatracurium 0.1 mg/kg: A quality assurance study. Acta Anaesthesiol Scand 2020; 64: 168-172
• 15 Vanlinthout LE, Driessen JJ, Stolker RJ. et al. Spontaneous recovery from neuromuscular block after a single dose of a muscle relaxant in pediatric patients: A systematic review using a network meta-analytic and meta-regression approach. Paediatr Anaesth 2024; 34: 720-733
• 16 Fuchs-Buder T, Romero CS, Lewald H. et al. Peri-operative management of neuromuscular blockade: A guideline from the European Society of Anaesthesiology and Intensive Care. Eur J Anaesthesiol 2023; 40: 82-94
• 17 Nemes R, Fulesdi B, Pongracz A. et al. Impact of reversal strategies on the incidence of postoperative residual paralysis after rocuronium relaxation without neuromuscular monitoring: A partially randomised placebo controlled trial. Eur J Anaesthesiol 2017; 34: 609-616
• 18 Naguib M, Brull SJ, Kopman AF. et al. Consensus Statement on Perioperative Use of Neuromuscular Monitoring. Anesth Analg 2018; 127: 71-80
• 19 Rodney G, Raju P, Brull SJ. Neuromuscular block management: evidence-based principles and practice. BJA Educ 2024; 24: 13-22
• 20 von Ungern-Sternberg BS, Boda K, Chambers NA. et al. Risk assessment for respiratory complications in paediatric anaesthesia: a prospective cohort study. Lancet 2010; 376: 773-783
• 21 Meakin GH. Role of muscle relaxants in pediatric anesthesia. Curr Opin Anaesthesiol 2007; 20: 227-231
• 22 Meretoja OA. Neuromuscular block and current treatment strategies for its reversal in children. Paediatr Anaesth 2010; 20: 591-604
• 23 Meretoja OA. Neuromuscular blocking agents in paediatric patients: influence of age on the response. Anaesth Intensive Care 1990; 18: 440-448
• 24 Thilen SR, Weigel WA, Todd MM. et al. 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Blockade: A Report by the American Society of Anesthesiologists Task Force on Neuromuscular Blockade. Anesthesiology 2023; 138: 13-41
• 25 Cha YM, Faulk DJ. Management of neuromuscular block in pediatric patients – safety implications. Current Anesthesiology Reports 2022; 12: 439-450
• 26 Owusu-Bediako K, Munch R, Mathias J. et al. Feasibility of intraoperative quantitative neuromuscular blockade monitoring in children using electromyography. Saudi J Anaesth 2022; 16: 412-418
• 27 Voss T, Wang A, DeAngelis M. et al. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study. Paediatr Anaesth 2022; 32: 436-445
• 28 Lang B, Han L, Zeng L. et al. Efficacy and safety of sugammadex for neuromuscular blockade reversal in pediatric patients: an updated meta-analysis of randomized controlled trials with trial sequential analysis. BMC Pediatr 2022; 22: 295
• 29 Gaver RS, Brenn BR, Gartley A. et al. Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children. Anesth Analg 2019; 129: 1124-1129
• 30 Alonso A, de Boer HD, Booij L. Reversal of rocuronium-induced neuromuscular block by sugammadex in neonates: 10AP1–3. Eur J Anaesthesiol 2014; 31: 163
• 31 Carlos RV, Torres ML, de Boer HD. Rocuronium and sugammadex in a 3 days old neonate for draining an ovarian cyst. Neuromuscular management and review of the literature. Braz J Anesthesiol 2016; 66: 430-432
• 32 Matsui M, Konishi J, Suzuki T. et al. Reversibility of Rocuronium-Induced Deep Neuromuscular Block with Sugammadex in Infants and Children-A Randomized Study. Biol Pharm Bull 2019; 42: 1637-1640
• 33 Lorinc AN, Lawson KC, Niconchuk JA. et al. Residual Weakness and Recurarization After Sugammadex Administration in Pediatric Patients: A Case Series. A A Pract 2020; 14: e01225
• 34 Kotake Y, Ochiai R, Suzuki T. et al. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013; 117: 345-351